Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant

BackgroundDonor specific antibodies (DSAs) can be responsible for graft failure (GF) in the setting of mismatched hematopoietic stem cell transplantation (HSCT). The aim of our study is to report the experience of the Madrid Group of Hematopoietic Transplant (GMTH) in patients with DSAs undergoing h...

Full description

Bibliographic Details
Main Authors: Rebeca Bailén, José Luis Vicario, Laura Solán, Irene Sánchez-Vadillo, Pilar Herrera, María Calbacho, Raquel Alenda, José Luis López-Lorenzo, Karem Humala, Anabelle Chinea, José Sánchez-Pina, Antonio Balas, Miguel Ángel Moreno, Javier Arzuaga, Virginia Pradillo, Nieves Dorado, Gillen Oarbeascoa, Javier Anguita, José Luis Díez-Martín, Mi Kwon
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Immunology
Subjects:
donor-specific anti HLA antibodies
haplo identical hematopoietic stem cell transplantation
Luminex ®
desensitization therapy
kinetics
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.674658/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.674658/full

Similar Items